Abstract
Over the past decades, a progressive and exponential aging of the population has been observed. In particular, an absolute e relative increase of old and very old persons is also projected for the next 30 years. This demographic phenomenon is substantially responsible for the growing prevalence of frailty in our societies. Frailty is a clinical condition characterized by an excessive vulnerability of the individual to endogenous and exogenous stressors. This status generates a high risk of developing negative health-related events. Shifting to a construct as frailty to biologically define the perimeter of action for geriatric medicine will probably concur at modernizing the old way of practicing medicine. In this chapter the concept of frailty, its impact on the evolving healthcare systems, the controversies associated with its assessment and, ultimately, the role it plays in the management of older persons are discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bandeen-Roche K, Seplaki CL, Huang J, Buta B, Kalyani RR, Varadhan R et al (2015) Frailty in older adults: a nationally representative profile in the United States. J Gerontol Ser A Biol Sci Med Sci 70:1427–1434. https://doi.org/10.1093/gerona/glv133
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380:37–43. https://doi.org/10.1016/S0140-6736(12)60240-2
British Geriatrics Society (2017) Royal college of general practitioners and age UK. Fit for Frailty—Consensus Best Practice Guidance for the care of older people living with frailty in community and outpatient settings: a report from the British Geriatrics Society
Buta BJ, Walston JD, Godino JG, Park M, Kalyani RR, Xue Q-L et al (2016) Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev 26:53–61. https://doi.org/10.1016/j.arr.2015.12.003
Castro HHG, Alencar AP, Benseor IM, Lotufo PA, Goulart AC (2017) Multimorbidities are associated to lower survival in Ischaemic stroke: results from a Brazilian stroke cohort (EMMA Study). Cerebrovasc Dis 44:232–239. https://doi.org/10.1159/000479827
Cesari M, Calvani R, Marzetti E (2017a) Frailty in older persons. Clin Geriatr Med 33:293–303. https://doi.org/10.1016/j.cger.2017.02.002
Cesari M, Marzetti E, Thiem U, Pérez-Zepeda MU, Abellan Van Kan G, Landi F et al (2016) The geriatric management of frailty as paradigm of “The end of the disease”. Eur J Intern Med 31:11–14. https://doi.org/10.1016/j.ejim.2016.03.005
Cesari M, Nobili A, Vitale G (2016b) Frailty and sarcopenia: From theory to clinical implementation and public health relevance. Eur J Intern Med 35:1–9. https://doi.org/10.1016/j.ejim.2016.07.021
Cesari M, Pérez-Zepeda MU, Marzetti E (2017b) Frailty and multimorbidity: different ways of thinking about geriatrics. J Am Med Dir Assoc 18:361–364. https://doi.org/10.1016/j.jamda.2016.12.086
Cesari M, Prince M, Thiyagarajan JA, De Carvalho IA, Bernabei R, Chan P et al (2016c) Frailty: an emerging public health priority. J Am Med Dir Assoc 17:188–192. https://doi.org/10.1016/j.jamda.2015.12.016
Collard RM, Boter H, Schoevers RA, Oude Voshaar RC (2012) Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc 60:1487–1492. https://doi.org/10.1111/j.1532-5415.2012.04054.x
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169
Fraccaro P, Kontopantelis E, Sperrin M, Peek N, Mallen C, Urban P et al (2016) Predicting mortality from change-over-time in the Charlson Comorbidity Index: a retrospective cohort study in a data-intensive UK health system. Medicine (Baltimore) 95:e4973. https://doi.org/10.1097/MD.0000000000004973
Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G (2011) Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol Ser A Biol Sci Med Sci 59:M255–M263. https://doi.org/10.1093/gerona/59.3.m255
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M146–M156
Mannucci PM, Nobili A (2014) Multimorbidity and polypharmacy in the elderly: lessons from REPOSI. Intern Emerg Med 9:723–734. https://doi.org/10.1007/s11739-014-1124-1
Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17:230. https://doi.org/10.1186/s12877-017-0621-2
Mitnitski AB, Mogilner AJ, Rockwood K (2001) Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal 1:323–336. https://doi.org/10.1100/tsw.2001.58
Morley JE, Vellas B, van Kan GA, Anker SD, Bauer JM, Bernabei R et al (2013) Frailty consensus: a call to action. J Am Med Dir Assoc 14:392–397. https://doi.org/10.1016/j.jamda.2013.03.022
Muth C, Blom JW, Smith SM, Johnell K, Gonzalez-Gonzalez AI, Nguyen TS et al (2019) Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med 285:272–288. https://doi.org/10.1111/joim.12842
National Institute for Health and Care Excellence (2017) Multimorbidity Overview
Payne RA (2016) The epidemiology of polypharmacy. Clin Med (Northfield Il) 16:465–469. https://doi.org/10.7861/clinmedicine.16-5-465
Poli S, Cella A, Puntoni M, Musacchio C, Pomata M, Torriglia D et al (2017) Frailty is associated with socioeconomic and lifestyle factors in community-dwelling older subjects. Aging Clin Exp Res 29:721–728. https://doi.org/10.1007/s40520-016-0623-5
Searle SD, Rockwood K (2018) What proportion of older adults in hospital are frail? Lancet 391:1751–1752. https://doi.org/10.1016/S0140-6736(18)30907-3
Tinetti ME, Fried T (2004) The end of the disease era. Am J Med 116:179–185
United Nations (2015) Department of Economic and Social Affairs, Population Division. World Population Ageing (ST/ESA/SER.A/390). 2015
Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R et al (2018) Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. https://doi.org/10.1093/gerona/gly110
WHO (2015) WHO World report on ageing and health 2015. World Health Organization. https://doi.org/10.1016/j.jmgm.2016.10.012
WHO (2017) Integrated care for older people : recommendations on interventions to manage declining physical and mental capacities in older people at community level
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Proietti, M., Cesari, M. (2020). Frailty: What Is It?. In: Veronese, N. (eds) Frailty and Cardiovascular Diseases . Advances in Experimental Medicine and Biology, vol 1216. Springer, Cham. https://doi.org/10.1007/978-3-030-33330-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-33330-0_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-33329-4
Online ISBN: 978-3-030-33330-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)